partnership to reach approval
Jastreboff, MD, PhD Director, Weight Management & Obesity Prevention Yale School of Medicine, New Haven, Connecticut Professor Ania Jastreboff has been a principal investigator for pivotal GLP3 clinical trials, including the landmark phase 2 obesity study published in the New England Journal of Medicine
WM has received industry funding and has attended events funded by Cobram Estate Pty Ltd
The Defense Departments own Operation Supplement safety site warns service members to stay clear of products containing BPC-157, which are sold online as research chemicals and carry statements such as Not for human consumption, Research use only, or For research purposes only. The marketed benefits of BPC-157 have only been shown in lab or animal studies (rats, mice, and dogs), the DoD supplement site states
This deficiency can result from insufficient intake through diet, limited sun exposure, impaired absorption, or other medical conditions